Article ; Online: Sexual dysfunction associated with major depressive disorder and antidepressant treatment.
2014 Volume 13, Issue 10, Page(s) 1361–1374
Abstract: Introduction: There is a well-established relationship between sexual functioning and quality of life. Depression can cause sexual dysfunction (SD) and its treatment can often lead to restoration of sexual functioning. Use of antidepressants has also ... ...
| Abstract | Introduction: There is a well-established relationship between sexual functioning and quality of life. Depression can cause sexual dysfunction (SD) and its treatment can often lead to restoration of sexual functioning. Use of antidepressants has also been associated with SD, with implications for treatment compliance and creation of further distress for the patient. Areas covered: This review evaluates available information regarding SD related to both depression and antidepressant treatment, including literature up to June 2014. It includes eligible published studies that investigated antidepressant-associated SD (AASD). Expert opinion: Depression and SD have a bidirectional association. When screening for depression, baseline sexual functioning should be assessed with validated rating scales. If sexual side effects develop with antidepressant treatment, management options include waiting for spontaneous remission, decreasing the medication dose, switching to an alternative drug or adding an augmentation agent or antidote. Research suggests that bupropion and newer antidepressants exhibit a more favorable SD profile compared with other antidepressants, especially selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors. Bupropion, mirtazapine and buspirone have been studied as augmentation agents/antidotes or substitution agents in management of AASD. Future studies validating genetic factors could enable personal genotyping to guide individualized treatment and also facilitate the development of enhanced therapeutic guidelines to avoid or manage AASD. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | Animals ; Antidepressive Agents/administration & dosage ; Antidepressive Agents/adverse effects ; Antidepressive Agents/therapeutic use ; Depressive Disorder, Major/complications ; Depressive Disorder, Major/drug therapy ; Genetic Predisposition to Disease ; Humans ; Medication Adherence ; Practice Guidelines as Topic ; Psychiatric Status Rating Scales ; Quality of Life ; Sexual Dysfunction, Physiological/chemically induced ; Sexual Dysfunction, Physiological/epidemiology ; Sexual Dysfunction, Physiological/etiology | |||||
| Chemical Substances | Antidepressive Agents | |||||
| Language | English | |||||
| Publishing date | 2014-10 | |||||
| Publishing country | England | |||||
| Document type | Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't ; Review | |||||
| ZDB-ID | 2088728-0 | |||||
| ISSN | 1744-764X ; 1474-0338 | |||||
| ISSN (online) | 1744-764X | |||||
| ISSN | 1474-0338 | |||||
| DOI | 10.1517/14740338.2014.951324 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 6096: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.